Nexien Biopharma Inc. (NXEN)

Overview

Nexien BioPharma, Inc. is a pioneering company focused on the research, development, and commercialization of cannabinoid-based pharmaceutical formulations. With a mission to advance the field of cannabinoid science, Nexien aims to create innovative solutions for treating various diseases, disorders, and medical conditions. Initially operating under the name Intiva BioPharma Inc., the company underwent a strategic rebranding in September 2018, adopting the name Nexien BioPharma, Inc. This strategic move reflected the company's evolving focus and ambition in the rapidly expanding arena of cannabinoid therapeutics. Nexien BioPharma, Inc., headquartered in Glendale, Colorado, is committed to leveraging cutting-edge technology and scientific research to pave the way for new treatment options in the pharmaceutical market.

Products and Services

Nexien BioPharma, Inc. is at the forefront of developing a range of products and services centered around cannabinoid-based pharmaceuticals. These offerings are designed to address a wide spectrum of medical needs, using the therapeutic potential of cannabinoids. Below are some of the key areas of development:

• Cannabinoid-Based Pharmaceuticals: Focused on the formulation and development of pharmaceuticals derived from cannabinoids. This includes drugs designed to treat specific diseases and conditions where cannabinoids have shown potential efficacy.
• Drug Delivery Systems: Developing advanced drug delivery systems tailored for cannabinoid medications. These systems are designed to optimize the delivery and effectiveness of cannabinoid treatments, ensuring patients receive the maximum benefit from their medications.
• Related Technologies: Apart from pharmaceuticals and drug delivery systems, Nexien BioPharma is also involved in the development of technologies that complement its main offerings. These include innovations that improve the production, effectiveness, and application of cannabinoid-based treatments.